Skip to main content
Zentiva 2 logo

Zentiva 2 — Investor Relations & Filings

Ticker · SKF ISIN · SK1120004439 LEI · 549300QOMTN6WGO3VV78 BSSE Manufacturing
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-03-17 Report Publication Anno…
Country SK Slovakia
Listing BSSE SKF

About Zentiva 2

https://www.zentiva.sk/

Zentiva is a pharmaceutical company that develops, manufactures, and markets a wide range of generic and over-the-counter (OTC) products. The company focuses on providing high-quality, affordable medicines to patients across Europe and other international markets. Its portfolio covers key therapeutic areas, including cardiology, oncology, and urology. Zentiva operates its own development centers to drive innovation and also engages in business-to-business collaborations through its Zent2U platform, which offers licensing-out of dossiers developed by the company.

Recent filings

Filing Released Lang Actions
Zentiva veroffentlicht Nachhaltigkeitsbericht 2025 und bekraftigt sein Engagement fur Menschen, Partner und den Planeten
Report Publication Announcement Classification · 100% confidence The document is a press release announcing the publication of the company's 2025 Sustainability Report. It provides a summary of key ESG highlights and includes a link to the full report, but it is not the report itself. According to the 'Menu vs Meal' rule, an announcement of a report's publication is classified as a Report Publication Announcement (RPA).
2026-03-17 German
Zentiva publishes 2025 Sustainability Report reinforcing commitment to people, partners and the planet.
Report Publication Announcement Classification · 100% confidence The document is a press release announcing the publication of the company's 2025 Sustainability Report. It provides a summary of key highlights and includes a link to the full report on the company's website. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2026-03-16 English
Zentiva fordert eine Aussetzung der UWWTD-Umsetzungsfristen auf EU-Ebene zum Schutz der Verfugbarkeit von Arzneimitteln
Regulatory Filings Classification · 95% confidence The document is a corporate press release issued by Zentiva regarding a legal decision by the Court of the European Union concerning the Urban Wastewater Treatment Directive (UWWTD). It details the company's stance, the potential impact on drug supply, and their call for regulatory action. As this is a general corporate announcement regarding legal/regulatory matters that does not fit into specific financial reporting categories like 10-K or ER, it is classified as a Regulatory Filing (RNS).
2026-02-24 German
Zentiva Demands EU-Level Stop-the-Clock on the UWWTD to Protect Medicine Availability
Legal Proceedings Report Classification · 95% confidence The document is a corporate press release issued by Zentiva regarding a legal matter involving the European Union's Urban Waste Water Treatment Directive (UWWTD). It discusses the company's legal action, the court's decision, and the potential impact on their business operations and medicine supply. Since it does not fit into specific financial reporting categories like 10-K, ER, or IR, and is not a report publication announcement, it falls under the 'Regulatory Filings' (RNS) category as a general corporate news announcement disseminated via a regulatory service (EQS).
2026-02-23 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.